Bulletin

Chorionic Gonadotropin (Human) Injection

06 November 2009

Products Affected - Description

Chorionic Gonadotropin (Human), lyophilized powder for injection
10,000 unit multiple-dose vial (NDC 63323-0025-10), APP Pharmaceuticals

Novarel 10,000 unit multiple-dose vial (NDC 55566-1501-01), Ferring Pharmaceuticals

Pregnyl 10,000 unit multiple-dose vial (NDC 00052-0315-10), Schering-Plough (formerly Organon)

Reason for the Shortage

APP Pharmaceuticals (formerly Abraxis Pharmaceutical Products), Ferring, and Schering Plough (formerly Organon) state this shortage is due to increased demand.

Estimated Resupply Dates

APP has their chorionic gonadotropin (human) injection (NDC 63323-0025-10) on allocation.
Ferring has their Novarel product (NDC 55566-1501-01) on allocation.
Schering Plough (formerly Organon) has Pregnyl injection (NDC 00052-0315-10) on allocation.

Related Shortages

Updated

November 6, 2009; October 2, 2009; September 21, 2009; August 25, 2009; July 23, 2009; June 15, 2009; May 18, 2009; April 24, 2009; March 23, 2009; February 20, 2009; January 9, 2009; November 3, 2008; October 6, 2008; August 25, 2008; July 28, 2008; June 2, 2008; May 5, 2008; April 8, 2008; March 10, 2008; February 21, 2008; January 29, 2008, University of Utah, Drug Information Service. Copyright 2009, Drug Information Service, University of Utah, Salt Lake City, UT.

Back to Drug Shortage Product Bulletins